Assignee
UCB BIOPHARMA SPRL
BE·122 granted patents·43 pending applications·570 citations·filing 2012–2022
Top patents by PatentIndex Score
165 records- 0197US10590197B2Antibody molecules which bind CD22UCB BIOPHARMA SPRL·Filed 2016·Granted Mar 17, 2020·14 cites·7 claims
- 0296US10358493B2Bispecific format suitable for use in high-through-put screeningUCB BIOPHARMA SPRL·Filed 2015·Granted Jul 23, 2019·14 cites·9 claims
- 0395US9499603B2PD-1 antibodiesUCB BIOPHARMA SPRL·Filed 2015·Granted Nov 22, 2016·19 cites·5 claims
- 0494US9873735B2Method of treatment with antibodies having specificity for human OX40UCB BIOPHARMA SPRL·Filed 2015·Granted Jan 23, 2018·12 cites·50 claims
- 0593US11059911B2Sequence symmetric modified IgG4 bispecific antibodiesUCB BIOPHARMA SPRL·Filed 2019·Granted Jul 13, 2021·8 cites·19 claims
- 0693US10829566B2Method employing bispecific antibodiesUCB BIOPHARMA SPRL·Filed 2016·Granted Nov 10, 2020·8 cites·17 claims
- 0793US10775385B2Treatment of autoimmune and inflammatory disorders with asymmetric TNF alpha trimersUCB BIOPHARMA SPRL·Filed 2015·Granted Sep 15, 2020·7 cites·4 claims
- 0893US10618957B2Antibody molecules which bind CD79UCB BIOPHARMA SPRL·Filed 2016·Granted Apr 14, 2020·9 cites·12 claims
- 0993US10370447B2Molecules with specificity for CD79 and CD22UCB BIOPHARMA SPRL·Filed 2015·Granted Aug 6, 2019·15 cites·11 claims
- 1092USD819804SInjectorUCB BIOPHARMA SPRL·Filed 2017·Granted Jun 5, 2018·48 cites·1 claims
- 1192US9333305B2Systems for automatically administering medicationUCB BIOPHARMA SPRL·Filed 2014·Granted May 10, 2016·42 cites·20 claims
- 1291US10221251B2Sequence symmetric modified IGG4 bispecific antibodiesUCB BIOPHARMA SPRL·Filed 2013·Granted Mar 5, 2019·11 cites·36 claims
- 1390US10774152B2Molecules with specificity for CD45 and CD79UCB BIOPHARMA SPRL·Filed 2015·Granted Sep 15, 2020·5 cites·12 claims
- 1489US10287343B2Tau-binding antibodiesUCB BIOPHARMA SPRL·Filed 2016·Granted May 14, 2019·5 cites·32 claims
- 1589US9969728B2Tetrahydroimidazopyridine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted May 15, 2018·14 cites·7 claims
- 1689US9789254B2Auto-injectorUCB BIOPHARMA SPRL·Filed 2015·Granted Oct 17, 2017·10 cites·25 claims
- 1788US10774157B2Multispecific antibodiesUCB BIOPHARMA SPRL·Filed 2016·Granted Sep 15, 2020·5 cites·17 claims
- 1888US10233243B2Anti-FcRn antibodiesUCB BIOPHARMA SPRL·Filed 2013·Granted Mar 19, 2019·10 cites·17 claims
- 1988US9803004B2Albumin binding antibodies and binding fragments thereofUCB BIOPHARMA SPRL·Filed 2012·Granted Oct 31, 2017·10 cites·11 claims
- 2088US9266953B2Methods of treating pain using function modifying NAv1.7 antibodiesUCB BIOPHARMA SPRL·Filed 2014·Granted Feb 23, 2016·8 cites·8 claims
- 2187US10889640B2Tau-binding antibodiesUCB BIOPHARMA SPRL·Filed 2019·Granted Jan 12, 2021·2 cites·10 claims
- 2287US10618979B2Multispecific antibodiesUCB BIOPHARMA SPRL·Filed 2016·Granted Apr 14, 2020·8 cites·11 claims
- 2387US9868749B2Fused imidazole and pyrazole derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Jan 16, 2018·16 cites·7 claims
- 2486US10344081B2Tau-binding antibodiesUCB BIOPHARMA SPRL·Filed 2016·Granted Jul 9, 2019·3 cites·38 claims
- 2586USD819805SInjectorUCB BIOPHARMA SPRL·Filed 2017·Granted Jun 5, 2018·29 cites·1 claims
- 2685US10829565B2Method for increasing the percentage of monomeric antibody Fab-dsFv multimeric speciesUCB BIOPHARMA SPRL·Filed 2016·Granted Nov 10, 2020·5 cites·22 claims
- 2785US9873703B2Imidazopyridazine derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Jan 23, 2018·8 cites·8 claims
- 2885US9821123B2Auto-injectorUCB BIOPHARMA SPRL·Filed 2015·Granted Nov 21, 2017·6 cites·21 claims
- 2984US10828366B2Method of monomerisation of recombinant antibody moleculesUCB BIOPHARMA SPRL·Filed 2016·Granted Nov 10, 2020·4 cites·15 claims
- 3084US10087179B2Fused tricyclic imidazole derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Oct 2, 2018·8 cites·11 claims
- 3184US9932343B2Fused tricyclic benzimidazoles derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Apr 3, 2018·10 cites·16 claims
- 3284US9908939B2AntibodiesUCB BIOPHARMA SPRL·Filed 2014·Granted Mar 6, 2018·6 cites·13 claims
- 3383US10421814B2AntibodiesUCB BIOPHARMA SPRL·Filed 2018·Granted Sep 24, 2019·3 cites·7 claims
- 3483US9890174B2Fused Tricyclic imidazole derivatives as modulators of TNF activityUCB BIOPHARMA SPRL·Filed 2014·Granted Feb 13, 2018·8 cites·16 claims
- 3582US10342925B2Auto-injectorUCB BIOPHARMA SPRL·Filed 2015·Granted Jul 9, 2019·5 cites·33 claims
- 3682US10273302B2Antibodies specific to FcRnUCB BIOPHARMA SPRL·Filed 2014·Granted Apr 30, 2019·5 cites·22 claims
- 3782US10202405B2Fused pentacyclic imidazole derivativesUCB BIOPHARMA SPRL·Filed 2015·Granted Feb 12, 2019·4 cites·11 claims
- 3882US10023631B2Albumin binding antibodies and binding fragments thereofUCB BIOPHARMA SPRL·Filed 2017·Granted Jul 17, 2018·3 cites·3 claims
- 3982US9988446B2Methods of treatment using antibodies which bind IL-17A and IL-17FUCB BIOPHARMA SPRL·Filed 2015·Granted Jun 5, 2018·2 cites·26 claims
- 4081US9957320B2Isolated DNA sequences encoding, and methods for making, antibody molecules having binding specificity for human IL-13UCB BIOPHARMA SPRL·Filed 2016·Granted May 1, 2018·3 cites·8 claims
- 4180US11384148B2Anti-FcRn antibodiesUCB BIOPHARMA SPRL·Filed 2019·Granted Jul 12, 2022·1 cites·16 claims
- 4280US10208349B2Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacyUCB BIOPHARMA SPRL·Filed 2013·Granted Feb 19, 2019·5 cites·6 claims
- 4379US10358460B2Protein manufactureUCB BIOPHARMA SPRL·Filed 2015·Granted Jul 23, 2019·3 cites·15 claims
- 4479US9764101B2Auto-injectorUCB BIOPHARMA SPRL·Filed 2013·Granted Sep 19, 2017·10 cites·42 claims
- 4578US10308723B2Method of treating inflammation by administering antibody molecules which bind IL-17A and IL-17FUCB BIOPHARMA SPRL·Filed 2017·Granted Jun 4, 2019·1 cites·9 claims
- 4677US10457748B2Single linker FabFv antibodies and methods of producing sameUCB BIOPHARMA SPRL·Filed 2013·Granted Oct 29, 2019·3 cites·24 claims
- 4777US10358443B2Heteroaryl amides as inhibitors of protein aggregationUCB BIOPHARMA SPRL·Filed 2017·Granted Jul 23, 2019·1 cites·4 claims
- 4877US9901686B2Systems and methods for administering medicationUCB BIOPHARMA SPRL·Filed 2013·Granted Feb 27, 2018·7 cites·13 claims
- 4977US9867941B2Auto-injector and drive unit thereforUCB BIOPHARMA SPRL·Filed 2013·Granted Jan 16, 2018·8 cites·26 claims
- 5077US9757524B2Auto-injectorUCB BIOPHARMA SPRL·Filed 2013·Granted Sep 12, 2017·9 cites·60 claims
Showing the top 50 of 165 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when UCB BIOPHARMA SPRL files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →